Tuesday, 18 February 2020

Japan News

  • Japan drug maker Novartis, in trouble again!

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: In an internal probing by the Novartis Pharma, it was revealed that its employees in Japan had failed to report about 10,000 cases of serious side effects caused by its drugs for...Read more

  • Spectrometry leader BiologicsFocus starts biologics initiative

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2012

    Singapore: AB SCIEX, a global leader in life science analytical technologies, announced a global initiative focused on biologics. This new initiative is in response to the fundamental shif...Read more

  • Eisai subsidiary opens antibody facility in the US

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2012

    Singapore: Eisai's US subsidiary Morphotek has opened a new pilot manufacturing plant in Exton, Pennsylvania, for the production of antibodies to support its early-stage clinical trials. Th...Read more

  • Riken launches joint research centers in India

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2013

    Singapore: Japan's largest research organization, Riken has launched two virtual Joint Research Centers with India's premier institution the National Center for Biological Sciences (NCBS), ...Read more

  • Mistubishi to elevate particle therapy portfolio

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2014

    Singapore: Japanese firm, Mitsubishi Electric Corporation, is gearing up to solidify its presence in the bioscience sector. The company has expanded its particle therapy business in Japan a...Read more

  • Daiichi Sankyo kids tumor drug gets Japanese nod

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2013

    Singapore: Daiichi Sankyo received approval for a supplemental new drug application (sNDA) for an additional indication for Topotecin intravenous drip infusion 40 mg and 100 mg (irinotecan ...Read more

  • Daiichi, Ranbaxy integrate Thailand business

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jan, 2013

    Singapore: Daiichi Sankyo and Ranbaxy Laboratories will integrate their business operations in Thailand, in order to leverage and maximize the synergies of the Hybrid Business Model. Accor...Read more

  • Takeda to acquire LigoCyte Pharmaceuticals

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

    Singapore: The wholly owned subsidiary of Japan-based Takeda Pharmaceutical, Takeda America Holdings, has entered into a definitive agreement with LigoCyte Pharmaceuticals to acquire LigoCy...Read more

  • Astellas, UCB launch Cimzia in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2013

    Singapore: Astellas Pharma and UCB Japan have launched Cimzia (certolizumab pegol) in Japan for adult patients with rheumatoid arthritis (RA) who have had an inadequate response to conventi...Read more

  • BabyLance safety heelstick receives EU patent

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2013

    Singapore: US-based MediPurpose, a master distributor and manufacturer of medical products, has announced an addition to its expanding portfolio of lancet patents. The medical product comp...Read more

  • Museum gets $250,000 from Takeda to train teachers

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 23 Oct, 2012

    Singapore: Takeda announced that it will donate $250,000 to Chicago's Museum of Science and Industry mainly to support science teacher education programs offered through the Museum's Cente...Read more

  • Eisai, Biogen boost manufacturing in US

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Dec, 2012

    Singapore: Eisai's US subsidiary entered into a strategic manufacturing alliance with Biogen Idec to bolster the manufacturing capabilities of both companies through the joint utilization ...Read more

  • KHK advances DsiRNA cancer target, pays $5 mn

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2013

    Singapore: Dicerna Pharmaceuticals, a RNA interference (RNAi) company focused on developing breakthrough oncology therapeutics, announced that Kyowa Hakko Kirin (KHK) has elected to advanc...Read more

  • BMS seeks Hep C therapy approval in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

    Singapore: Bristol-Myers Squibb has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices Agency seeking the world's first interferon-free and ribavirin-free ...Read more

  • Daiichi US appoints Glenn Gormley as chairman

    Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2013

    Singapore: Daiichi Sankyo has appointed Dr Glenn Gormley, as president and chairman of Daiichi Sankyo, US. Dr Gormley will also continue in his existing roles as president, Daiichi Sankyo ...Read more

  • Catalent, UMN collaborate for biosimilars

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

    Singapore: Catalent Pharma Solutions and UMN Pharma announced the signing of an agreement to provide UMN Pharma a broad range of biosimilar cell lines using Catalent's proprietary GPEx te...Read more

  • Daiichi Sankyo generics' unit to launch 5 drugs

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Dec, 2012

    Singapore: Daiichi Sankyo's pharmaceuticals subsidiary, Daiichi Sankyo Espha is all set to launch five generic products Quetiapine tablets 25 mg DSEP, Quetiapine tablets 100 mg DSEP and Que...Read more

  • Medtronic to help rebuild hospital in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

    Singapore: Medtronic Foundation will partner with Project HOPE to rebuild the Yamada General Hospital in Japan's northern coastal town of Yamada. The hospital was destroyed in the earthquak...Read more